Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation

Cancer Research Fund consistently dedicates high percentage of spending to programs with zero officer compensation.

EIN: 131933825 · New York, NY · NTEE: E120 · Updated: 2026-03-28

$46.9MRevenue
$19.6MGross Revenue
$160.5MAssets
92/100Mission Score (Excellent)
E120
Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation Financial Summary
MetricValue
Total Revenue$46.9M
Total Expenses$21.2M
Program Spending85%
CEO/Top Officer Pay$160
Net Assets$114.8M
Transparency Score92/100

Is Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation Legit?

Appears Legitimate

GoodFiling Consistency
ExcellentSpending Efficiency
GoodTransparency
NoneRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation

Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation (EIN: 131933825) is a nonprofit organization based in New York, NY, classified under NTEE code E120. The organization reported total revenue of $46.9M and total assets of $160.5M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

79Years Operating
LargeSize Classification
13Years of Filings
MixedRevenue Trajectory

Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation is a large nonprofit that has been operating for 79 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of -0.2%.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

Total Revenue$15.7M
Total Expenses$21.2M
Surplus / Deficit$-5,503,541
Total Assets$147.7M
Total Liabilities$32.9M
Net Assets$114.8M
Operating Margin-35.0%
Debt-to-Asset Ratio22.3%
Months of Reserves83.5 months

Financial Health Grade: B

In 2023, Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation reported a deficit of $5.5M with expenses exceeding revenue, holds 83.5 months of operating reserves (strong position), has a debt-to-asset ratio of 22.3% (moderate leverage).

Financial Trends

Over 13 years of filings (2011–2023), Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation's revenue has declined at a compound annual growth rate (CAGR) of -0.2%.

YearRevenue ChangeExpense ChangeAsset Change
2023+9.2%-1.7%+2.9%
2022-30.0%+6.1%-18.2%
2021-62.1%-12.8%+18.5%
2020+158.3%-7.8%-1.6%
2019-2.6%+19.3%+1.2%

IRS Tax-Exempt Classification

IRS Classification Codes1000
IRS Ruling Date1947

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Transparency Report

The Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation demonstrates a strong commitment to its mission, consistently allocating a significant portion of its expenses to program services. For instance, in the 202306 period, 85% of its $21,219,216 in expenses went directly to programs, with 10% for administrative costs and 5% for fundraising. This indicates efficient spending towards its cancer research goals. The organization also maintains a healthy asset base, with $147,680,687 in assets against $32,920,972 in liabilities in the latest filing, suggesting financial stability. While revenue has fluctuated over the years, notably a peak of $54,248,600 in 202006, the organization has managed its expenses effectively, generally keeping them below or near revenue levels, except for a few periods like 202306 where expenses slightly exceeded revenue. The consistent reporting of 0% officer compensation across all available filings is a significant positive indicator of transparency and a focus on mission over executive enrichment. This practice enhances public trust and demonstrates a strong ethical stance regarding financial management. Overall, the foundation appears to be a financially sound and well-managed organization, prioritizing its program services and maintaining a high degree of transparency regarding executive compensation. Its substantial assets provide a buffer for future operations and program expansion, reinforcing its long-term viability in supporting cancer research.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

  • admin: 10%
  • programs: 85%
  • fundraising: 5%

According to IRS 990 filings, Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

$15.7MTotal Revenue
$21.2MTotal Expenses
$147.7MTotal Assets
$32.9MTotal Liabilities
$114.8MNet Assets
  • The organization reported a deficit of $5.5M, with expenses exceeding revenue.
  • Debt-to-asset ratio: 22.3%.

Executive Compensation Analysis

Executive compensation is reported as 0% across all available filings, indicating that no officers received compensation from the organization, which is highly commendable for an organization of its size with assets exceeding $160 million.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Strengths

The following positive indicators were identified for Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation:

  • High program spending ratio (85% in 202306)
  • Zero officer compensation reported across all filings
  • Strong asset base ($160,511,709 latest assets)
  • Consistent financial transparency
  • Healthy asset-to-liability ratio

Frequently Asked Questions about Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation

Is Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation a legitimate charity?

Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation (EIN: 131933825) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 92/100. It has 13 years of IRS 990 filings on record. Total revenue: $46.9M. No red flags identified. 5 strengths noted. Financial health grade: B.

How does Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation spend its money?

Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.

Are donations to Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation tax-deductible?

Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation is registered as a tax-exempt nonprofit (EIN: 131933825). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

How much does the Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation CEO make?

Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation's highest-compensated officer earns $160 annually. The organization reported $46.9M in total revenue. Executive compensation data is disclosed in IRS 990 filings.

What percentage of Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation's spending goes to programs?

Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.

How does Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation compare to similar nonprofits?

With a transparency score of 92/100 (Excellent), Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation is above average for NTEE category E120 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.

Where is Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation located?

Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation is headquartered in New York, New York and files with the IRS under EIN 131933825. It is classified under NTEE code E120.

How many years of IRS 990 filings does Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation have?

Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $46.9M in total revenue.

Is Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation a good charity?

Based on the provided data, the organization appears to be a very good charity. It consistently allocates a high percentage of its expenses to program services (85% in 202306) and reports 0% officer compensation, demonstrating strong financial efficiency and transparency.

How stable is the organization's financial position?

The organization maintains a strong financial position with substantial assets ($147,680,687 in 202306) significantly outweighing its liabilities ($32,920,972), indicating good financial stability and capacity for long-term operations.

What is the trend in the organization's revenue?

Revenue has fluctuated, with a notable peak of $54,248,600 in 202006, but generally ranges between $12 million and $26 million in other periods. The latest reported revenue is $15,715,675 (202306).

Filing History

IRS 990 filing history for Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation's revenue has declined by 1.9%, moving from $16.0M to $15.7M. Total assets increased by 38.7% over the same period, from $106.5M to $147.7M. Total functional expenses rose by 56.7%, from $13.5M to $21.2M. In its most recent filing year (2023), Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation reported a deficit of $5.5M, with expenses exceeding revenue. The organization holds $32.9M in liabilities against $147.7M in assets (debt-to-asset ratio: 22.3%), resulting in net assets of $114.8M.

YearRevenueExpensesAssetsLiabilitiesOfficer Comp. %PDF
2023 $15.7M $21.2M $147.7M $32.9M View 990
2022 $14.4M $21.6M $143.5M $31.9M View 990
2021 $20.6M $20.4M $175.6M $32.6M View 990
2020 $54.2M $23.3M $148.1M $35.5M View 990
2019 $21.0M $25.3M $150.5M $35.5M View 990
2018 $21.6M $21.2M $148.7M $32.2M View 990
2017 $16.6M $19.6M $142.4M $30.3M View 990
2016 $12.2M $21.5M $135.6M $29.8M View 990
2015 $26.1M $17.7M $145.4M $25.9M View 990
2014 $16.7M $20.7M $138.3M $26.6M View 990
2013 $20.3M $16.0M $123.9M $21.3M View 990
2012 $12.0M $15.2M $107.1M $19.5M View 990
2011 $16.0M $13.5M $106.5M $17.2M View 990

Year-by-Year Financial Summary

  • 2023: Revenue of $15.7M, expenses of $21.2M, and assets of $147.7M (revenue +9.2% year-over-year).
  • 2022: Revenue of $14.4M, expenses of $21.6M, and assets of $143.5M (revenue -30.0% year-over-year).
  • 2021: Revenue of $20.6M, expenses of $20.4M, and assets of $175.6M (revenue -62.1% year-over-year).
  • 2020: Revenue of $54.2M, expenses of $23.3M, and assets of $148.1M (revenue +158.3% year-over-year).
  • 2019: Revenue of $21.0M, expenses of $25.3M, and assets of $150.5M (revenue -2.6% year-over-year).
  • 2018: Revenue of $21.6M, expenses of $21.2M, and assets of $148.7M (revenue +30.3% year-over-year).
  • 2017: Revenue of $16.6M, expenses of $19.6M, and assets of $142.4M (revenue +35.2% year-over-year).
  • 2016: Revenue of $12.2M, expenses of $21.5M, and assets of $135.6M (revenue -53.0% year-over-year).
  • 2015: Revenue of $26.1M, expenses of $17.7M, and assets of $145.4M (revenue +56.1% year-over-year).
  • 2014: Revenue of $16.7M, expenses of $20.7M, and assets of $138.3M (revenue -17.8% year-over-year).
  • 2013: Revenue of $20.3M, expenses of $16.0M, and assets of $123.9M (revenue +69.9% year-over-year).
  • 2012: Revenue of $12.0M, expenses of $15.2M, and assets of $107.1M (revenue -25.3% year-over-year).
  • 2011: Revenue of $16.0M, expenses of $13.5M, and assets of $106.5M.

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation:

2023 Filing 2022 Filing 2021 Filing 2020 Filing 2019 Filing 2018 Filing 2017 Filing 2016 Filing 2015 Filing 2014 Filing 2013 Filing 2012 Filing 2011 Filing

Data Sources and Methodology

This transparency report for Cancer Research Fund Of The Damon Runyon Walter Winchell Foundation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Other Nonprofits in New York

Explore more nonprofits based in New York with AI-powered transparency reports.

View all New York nonprofits →

Similar Organizations (NTEE E120)

Other nonprofits classified under NTEE code E120.

View all E120 nonprofits →

Explore Related Nonprofits

Browse by State